Clinical Trials Directory

Trials / Terminated

TerminatedNCT01723397

Effect of Nasaleze on Nasal Challenge With Allergen

Effect of Nasaleze on the Early Reaction to Nasal Challenge With Allergen

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
14 (actual)
Sponsor
University of Chicago · Academic / Other
Sex
All
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

The objectives of this protocol are: 1. to confirm the inhibitory effect of Nasaleze on the immediate response to nasal challenge with antigen, and 2. to show that inhibition of the immediate response to nasal challenge with antigen by Nasaleze inhibits subsequent inflammatory events.

Conditions

Interventions

TypeNameDescription
DRUGNasaleze SpraySubjects are treated with over the counter Nasaleze cellulose powder nasal spray then challenged with allergen
OTHERPlacebo spraySubjects are treated with placebo nasal spray then challenged with allergen
BIOLOGICALAllergenSubjects are challenged with grass or ragweed allergen after treatment with Nasaleze or placebo

Timeline

Start date
2012-11-01
Primary completion
2014-07-01
Completion
2014-07-01
First posted
2012-11-07
Last updated
2017-01-02
Results posted
2016-10-27

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01723397. Inclusion in this directory is not an endorsement.

Effect of Nasaleze on Nasal Challenge With Allergen (NCT01723397) · Clinical Trials Directory